Incidence and Outcomes of Atrial Fibrillation and Systolic Dysfunction in Patients Receiving Mavacamten for Obstructive Hypertrophic Cardiomyopathy: A Multicenter Study

Journal of Cardiac Failure · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles